title: HMCO5, herbal extract, inhibits NF-kappaB expression in lipopolysaccharide treated macrophages and reduces atherosclerotic lesions in cholesterol fed mice.
abstract: HMCO5 is a herbal extract which comprises of eight different herbs. We studied whether this extract has anti-atherosclerotic effects. In lipopolysaccharide (LPS) stimulated RAW264.7 cells, HMCO5 inhibited NF-kappaB activation as well as iNOS promoter activity, inhibited the secretion of TNF-alpha and IL-1beta, and directly inhibited the intracellular accumulation of reactive oxygen species. ApoE knock-out mice fed a high-fat high-cholesterol diet with HMCO5 for 10 weeks showed a significant reduction in atherosclerotic lesions. A notable finding was the preservation of the smooth muscle cell layer in the media of aorta in the HMCO5 co-treated mice. HMCO5 treated mice did not show significant decrease in serum level of cholesterol. These results suggest that HMCO5 has anti-atherosclerotic effects which in part may be attributable to the inhibition of production of NF-kappaB dependent pro-inflammatory cytokines.
authors.affiliation: Division of Cardiology, Samsung Medical Center & Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Seoul, South Korea.
authors.forename: Ki Mo
authors.initials: KM
authors.lastname: Kim
authors.forename: Jin Yong
authors.initials: JY
authors.lastname: Choi
authors.forename: Si-Eun
authors.initials: SE
authors.lastname: Yoo
authors.forename: Mi Young
authors.initials: MY
authors.lastname: Park
authors.forename: Bok-Soo
authors.initials: BS
authors.lastname: Lee
authors.forename: Young Hye
authors.initials: YH
authors.lastname: Ko
authors.forename: Sang Hyun
authors.initials: SH
authors.lastname: Sung
authors.forename: Heung-Mook
authors.initials: HM
authors.lastname: Shin
authors.forename: Jeong Euy
authors.initials: JE
authors.lastname: Park
mesh_terms: D021581:Active Transport, Cell Nucleus / Q000187:drug effects; D000818:Animals; D001057:Apolipoproteins E / Q000502:physiology; D050197:Atherosclerosis / Q000188:drug therapy*; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D052246:Cyclooxygenase 2 Inhibitors / Q000494:pharmacology; D053583:Interleukin-1beta / Q000037:antagonists & inhibitors; D008070:Lipopolysaccharides / Q000494:pharmacology; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D019255:NADPH Oxidases / Q000037:antagonists & inhibitors; D016328:NF-kappa B / Q000037:antagonists & inhibitors*; D052247:Nitric Oxide Synthase Type II / Q000037:antagonists & inhibitors; D010936:Plant Extracts / Q000494:pharmacology* / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D001057:Apolipoproteins E; D002791:Cholesterol, Dietary; D052246:Cyclooxygenase 2 Inhibitors; C526235:HMCO5 herbal extract; D053583:Interleukin-1beta; D008070:Lipopolysaccharides; D016328:NF-kappa B; D010936:Plant Extracts; D014409:Tumor Necrosis Factor-alpha; D052247:Nitric Oxide Synthase Type II; C496317:Nos2 protein, mouse; D019255:NADPH Oxidases